Sign in

Moderna, Inc.

Income Statement - Moderna, Inc. (MRNA)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14
Total revenue 1.94 3.20 6.85 18.88 17.74 0.27 0.05 0.12 0.21 0.11 0.00 0.00
Cost of revenue 0.87 1.46 4.69 5.42 2.62 0.01 0.50 0.45 0.02 0.02 0.00 0.00
Gross profit 1.08 1.74 2.16 13.46 15.12 0.27 0.05 -0.33 0.19 0.09 0.00 0.00
Total operating expenses + 4.15 5.68 6.39 4.04 1.82 1.03 0.59 0.54 0.45 0.32 0.00 0.00
Operating income -3.07 -3.95 -4.24 9.42 13.30 -0.76 -0.55 -0.41 -0.27 -0.22 0.00 0.00
Non-operating income (net) 0.31 0.34 0.30 0.16 -0.01 0.02 0.03 0.03 0.01 0.01 0.00 0.00
Income before tax -2.77 -3.61 -3.94 9.58 13.29 -0.74 -0.51 -0.38 -0.26 -0.22 0.00 -0.01
Income tax expense 0.05 -0.05 0.77 1.21 1.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -2.82 -3.56 -4.71 8.36 12.20 -0.75 -0.51 -0.38 -0.26 -0.22 0.00 -0.01
Show Quarterly Income Statement

Income Statement - Moderna, Inc. (MRNA)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16
Total revenue 0.39 0.68 1.02 0.14 0.11 0.96 1.86 0.22 0.17 2.81 1.83 0.34 1.84 5.15 3.22 4.57 5.94 6.95 4.83 4.22 1.74 0.57 0.16 0.07 0.01 0.01 0.02 0.01 0.02 0.04 0.04 0.03 0.03 0.09 0.04 0.04 0.04 0.11
Cost of revenue 0.96 0.45 1.01 0.12 0.09 0.74 0.51 0.12 0.10 0.93 2.24 0.73 0.79 1.92 1.10 1.38 1.02 0.95 0.72 0.75 0.19 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.10 0.09 0.01 0.01 0.10 0.10 0.32
Gross profit -0.57 0.23 0.01 0.02 0.02 0.22 1.34 0.11 0.07 1.88 -0.41 -0.39 1.05 3.23 2.12 3.19 4.92 6.00 4.11 3.47 1.55 0.56 0.15 0.06 0.00 0.01 0.01 0.01 0.01 0.03 0.04 -0.08 -0.06 0.09 0.04 -0.06 -0.06 -0.17
Total operating expenses + 0.82 1.08 0.27 0.93 1.07 1.46 1.41 1.47 1.34 1.88 1.60 1.48 1.41 1.65 0.95 0.74 0.70 0.59 0.55 0.40 0.28 0.83 0.38 0.18 0.13 0.14 0.14 0.15 0.03 0.18 0.12 0.02 0.02 0.13 0.29 0.02 0.02 0.33
Operating income -1.39 -0.86 -0.26 -0.91 -1.05 -1.25 -0.07 -1.36 -1.27 0.01 -2.01 -1.87 -0.37 1.58 1.17 2.45 4.23 5.41 3.56 3.06 1.27 -0.28 -0.24 -0.12 -0.13 -0.13 -0.13 -0.14 -0.14 -0.15 -0.09 -0.10 -0.08 -0.04 -0.07 -0.08 -0.08 -0.22
Non-operating income (net) 0.05 0.06 0.07 0.09 0.09 0.06 0.09 0.08 0.10 0.06 0.05 0.12 0.06 0.08 0.05 0.03 0.00 0.00 -0.01 0.00 -0.01 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.01
Income before tax -1.33 -0.80 -0.19 -0.82 -0.96 -1.18 0.02 -1.28 -1.17 0.07 -1.96 -1.75 -0.31 1.66 1.22 2.47 4.23 5.41 3.55 3.06 1.26 -0.27 -0.23 -0.12 -0.12 -0.12 -0.12 -0.14 -0.13 -0.14 -0.08 -0.09 -0.07 -0.04 -0.06 -0.08 -0.08 -0.22
Income tax expense 0.01 0.03 0.01 0.01 0.01 -0.06 0.01 0.01 -0.15 1.67 -0.37 -0.38 0.19 0.17 0.28 0.57 0.54 0.22 0.28 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -1.34 -0.83 -0.20 -0.83 -0.97 -1.12 0.01 -1.28 -1.18 0.22 -3.63 -1.38 0.08 1.47 1.04 2.20 3.66 4.87 3.33 2.78 1.22 -0.27 -0.23 -0.12 -0.12 -0.12 -0.12 -0.14 -0.13 -0.14 -0.08 -0.09 -0.07 -0.04 -0.07 -0.08 -0.08 -0.22
about 2 months ago

Balance Sheet - Moderna, Inc. (MRNA)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14
Total cash and short-term investments + 5.80 7.03 8.60 9.90 10.73 4.61 1.10 1.52 0.76 1.06 0.00 0.00
Accounts receivable, net 0.28 0.59 1.08 1.69 3.32 1.41 0.02 0.03 0.02 0.02 0.00
Inventories 0.15 0.12 0.20 0.95 1.44 0.05 -0.90 -0.17
Other current assets 0.31 0.37 0.44 0.90 0.58 0.24 0.01 0.01 0.01 0.01 0.00
Total current assets 6.54 8.10 10.33 13.43 16.07 6.30 1.13 1.56 0.78 1.09 0.00 0.00
Total non-current assets + 5.79 6.04 8.10 12.43 8.60 1.04 0.46 0.40 0.30 0.33
Total assets 12.34 14.14 18.43 25.86 24.67 7.34 1.59 1.96 1.08 1.42 0.00 0.01
Total current liabilities + 1.99 2.21 3.02 4.92 9.13 4.39 0.14 0.22 0.19 0.16 0.00 0.00
Total non-current liabilities + 1.70 1.04 1.56 1.81 1.40 0.39 0.27 0.21 0.27 0.41
Total liabilities 3.69 3.24 4.57 6.74 10.52 4.78 0.41 0.43 0.46 0.58 0.00 0.01
Total stockholders' equity + 8.65 10.90 13.85 19.12 14.15 2.56 1.17 1.53 0.63 0.84 0.00 0.00
Common shares outstanding 389 384 382 416 431 381 331 81 376 376 61
Show Quarterly Balance Sheet

Balance Sheet - Moderna, Inc. (MRNA)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16
Total cash and short-term investments + 5.21 5.80 4.50 5.13 5.98 7.03 6.87 8.49 8.52 8.60 7.57 8.46 8.92 9.90 8.35 7.90 10.12 10.73 8.91 7.99 7.74 4.61 3.28 2.72 1.22 1.10 1.06 1.07 1.11 1.52 1.07 1.11 0.76 0.76 0.00 0.00 1.06 1.06
Accounts receivable, net 0.15 0.28 1.39 0.46 0.31 0.59 1.84 0.42 0.39 1.08 2.15 0.69 1.52 1.69 2.82 2.84 3.36 3.32 3.20 2.07 3.23 1.41 0.21 0.06 0.02 0.02 0.03 0.02 0.02 0.03 0.01 0.01 0.02 0.02 0.02
Inventories 0.15 0.15 0.33 0.24 0.13 0.12 0.41 0.40 0.30 0.20 0.49 0.72 0.73 0.95 2.08 1.92 1.94 1.44 0.97 0.64 0.49 0.05 -0.69 -0.35 -0.03 -0.03 -0.03 -0.17 0.00 0.00
Other current assets 0.27 0.31 0.37 0.34 0.36 0.37 0.55 0.35 0.40 0.44 0.59 0.74 0.95 0.90 1.05 0.90 0.93 0.58 0.36 0.27 0.25 0.24 0.09 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.03 0.04 0.00 0.01 0.00 0.00 0.00 0.01
Total current assets 5.77 6.54 6.60 6.17 6.77 8.10 9.67 9.66 9.60 10.33 10.80 10.60 12.12 13.43 14.30 13.56 16.35 16.07 13.43 10.97 11.70 6.30 3.58 2.80 1.25 1.13 1.09 1.44 1.55 1.56 1.12 1.16 0.76 0.78 0.00 0.00 1.06 1.09
Total non-current assets + 5.72 5.79 5.54 5.84 5.94 6.04 6.14 6.02 7.13 8.10 8.65 11.29 12.00 12.43 11.76 12.48 11.26 8.60 7.50 5.18 0.99 1.04 1.07 0.69 0.82 0.46 0.50 0.25 0.26 0.40 0.37 0.44 -0.76 0.30 -1.06
Total assets 11.49 12.34 12.14 12.01 12.70 14.14 15.80 15.68 16.73 18.43 19.45 21.88 24.13 25.86 26.06 26.04 27.61 24.67 20.92 16.15 12.69 7.34 4.65 3.49 2.07 1.59 1.59 1.69 1.81 1.96 1.49 1.60 1.60 1.08 0.01 0.01 0.01 1.42
Total current liabilities + 2.40 1.99 1.68 1.57 1.60 2.21 2.20 2.36 2.38 3.02 4.39 3.12 3.50 4.92 6.81 6.81 9.24 9.13 9.96 8.84 8.44 4.39 1.47 0.16 0.13 0.14 0.15 0.16 0.16 0.22 0.19 0.20 0.20 0.19 0.00 0.00 0.00 0.16
Total non-current liabilities + 1.69 1.70 1.12 1.04 1.03 1.04 1.68 1.61 1.53 1.56 1.61 1.81 1.76 1.81 1.26 1.25 1.30 1.40 0.84 0.61 0.42 0.39 0.42 0.38 0.29 0.27 0.19 0.18 0.20 0.21 0.23 0.25 0.27
Total liabilities 4.08 3.69 2.81 2.61 2.64 3.24 3.88 3.97 3.91 4.57 6.00 4.94 5.26 6.74 8.06 8.06 10.53 10.52 10.80 9.45 8.86 4.78 1.89 0.54 0.43 0.41 0.34 0.35 0.36 0.43 0.41 0.45 0.45 0.46 0.00 0.00 0.00 0.58
Total stockholders' equity + 7.41 8.65 9.33 9.40 10.07 10.90 11.93 11.71 12.82 13.85 13.46 16.95 18.86 19.12 17.99 17.99 17.08 14.15 10.12 6.70 3.84 2.56 2.76 2.95 1.64 1.17 1.25 1.34 1.45 1.53 1.08 1.15 0.63 0.63 0.00 0.00 0.84 0.84
Common shares outstanding 395 392 390 388 386 385 399 384 382 395 381 381 405 405 412 419 426 431 434 431 430 397 395 381 353 334 331 329 329 329 324 395 395 297 65 64 64
about 2 months ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14
Operating cash flow + -1.87 -3.00 -3.12 4.98 13.62 2.03 -0.46 -0.33 -0.33 0.07 0.00 0.00
Cash flow from investing + 1.95 1.95 4.21 -5.18 -8.52 -1.67 -0.01 -0.37 0.42 -0.65 0.00 0.00
Cash flow from financing + 0.59 0.06 -1.38 -3.45 -0.87 2.03 0.05 1.23 0.00 0.47 0.00 0.01
Change in cash 0.67 -1.00 -0.29 -3.64 4.22 2.39 -0.42 0.52 0.08 -0.11 0.00 0.00
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16
Operating cash flow + -0.63 0.95 -0.85 -0.92 -1.04 0.83 -1.57 -1.27 -0.99 0.62 -1.60 -0.92 -1.23 1.66 0.25 0.30 2.76 3.31 3.28 4.06 2.97 1.26 0.89 -0.02 -0.11 -0.10 -0.11 -0.11 -0.14 -0.09 -0.08 -0.05 -0.11 -0.10 -0.04 -0.09 -0.09 0.07
Cash flow from investing + -0.08 -0.05 0.70 0.56 0.73 -0.54 0.72 1.65 0.12 -0.54 0.79 1.94 2.01 -1.05 0.95 -1.15 -3.92 -1.14 -3.33 -3.88 -0.18 -0.19 -1.18 0.01 -0.32 0.13 0.11 -0.25 -0.01 0.01 0.12 -0.01 -0.48 0.11 0.01 0.14 0.14 -0.65
Cash flow from financing + 0.02 0.56 0.00 0.01 0.00 0.00 0.01 0.03 0.01 -0.11 -0.06 -0.67 -0.54 -0.44 -1.04 -1.33 -0.64 -0.87 0.00 -0.02 0.03 0.04 0.03 1.38 0.58 0.03 0.02 0.01 0.00 0.58 -0.01 0.11 0.55 0.00 0.00 0.00 0.00 0.47
Change in cash -0.69 1.46 -0.15 -0.35 -0.30 0.28 -0.83 0.41 -0.86 -0.03 -0.87 0.36 0.24 0.18 0.16 -2.18 -1.80 1.30 -0.05 0.16 2.82 1.12 -0.26 1.37 0.16 0.06 0.02 -0.35 -0.16 0.49 0.03 0.05 -0.05 0.01 -0.03 0.05 0.05 -0.11
about 2 months ago

Moderna, Inc. (MRNA) - Current Long Term Debt

1Y 2Y 5Y Max
about 2 months ago

Moderna, Inc. (MRNA) - Common Stock

1Y 2Y 5Y Max
about 2 months ago

Moderna, Inc. (MRNA) - Property Plant Equipment

1Y 2Y 5Y Max
about 2 months ago

Moderna, Inc. (MRNA) - Short Term Debt

1Y 2Y 5Y Max
about 2 months ago

Moderna, Inc. (MRNA) - Common Stock Shares Outstanding

1Y 2Y 5Y Max
about 2 months ago

Moderna, Inc. (MRNA) - Retained Earnings

1Y 2Y 5Y Max
about 2 months ago

Moderna, Inc. (MRNA) - Total Shareholder Equity

1Y 2Y 5Y Max
about 2 months ago

Moderna, Inc. (MRNA) - Other Non Current Liabilities

1Y 2Y 5Y Max
about 2 months ago

Moderna, Inc. (MRNA) - Other Current Liabilities

1Y 2Y 5Y Max
about 2 months ago

Moderna, Inc. (MRNA) - Short Long Term Debt Total

1Y 2Y 5Y Max
about 2 months ago